je.st
news
Home
› This Week In Pharma: Questions On Lilly's Solanezumab Trial Amendments, BioDelivery's BELBUCA
This Week In Pharma: Questions On Lilly's Solanezumab Trial Amendments, BioDelivery's BELBUCA
2016-03-22 16:12:08| Biotech - Topix.net
This week's column presents questions on Lilly's solanezumab trial and BELBUCA. Based on your votes for the more interesting topic, Slingshot Insights will interview an expert and post a transcript.
Tags: questions
week
trial
amendments
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|